A detailed history of Ascent Group, LLC transactions in Haleon PLC stock. As of the latest transaction made, Ascent Group, LLC holds 33,218 shares of HLN stock, worth $318,560. This represents 0.01% of its overall portfolio holdings.

Number of Shares
33,218
Previous 133,093 75.04%
Holding current value
$318,560
Previous $1.38 Million 78.48%
% of portfolio
0.01%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

SELL
$8.72 - $10.35 $870,910 - $1.03 Million
-99,875 Reduced 75.04%
33,218 $297,000
Q2 2025

Jul 21, 2025

BUY
$9.27 - $11.41 $721,437 - $887,983
77,825 Added 140.81%
133,093 $1.38 Million
Q1 2025

May 15, 2025

BUY
$9.02 - $10.67 $498,517 - $589,709
55,268 New
55,268 $568,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Ascent Group, LLC Portfolio

Follow Ascent Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Group, LLC with notifications on news.